Mark Tye
Scientist, Revolution Medicines
Enrollment Year - 2016
Mazitschek Lab - Massachusetts General Hospital
Advisor: Ralph Mazitschek
Thesis: An integrated chemogenomic approach exploring and exploiting prolyl-tRNA synthetase as target for next-generation malaria and cancer therapies